F. Faurisson

1.0k total citations
26 papers, 773 citations indexed

About

F. Faurisson is a scholar working on Pharmacology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, F. Faurisson has authored 26 papers receiving a total of 773 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pharmacology, 8 papers in Pulmonary and Respiratory Medicine and 3 papers in Surgery. Recurrent topics in F. Faurisson's work include Antibiotics Pharmacokinetics and Efficacy (9 papers), Inhalation and Respiratory Drug Delivery (7 papers) and Cystic Fibrosis Research Advances (4 papers). F. Faurisson is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (9 papers), Inhalation and Respiratory Drug Delivery (7 papers) and Cystic Fibrosis Research Advances (4 papers). F. Faurisson collaborates with scholars based in France, United States and Switzerland. F. Faurisson's co-authors include Frédérique Delatour, H. Gastinne, Sylvie Chevret, Matthias Wolff, B Rouveix, Guy Couarraze, Florence Agnely, Sandrine Geiger, Laurent Massias and C Carbon and has published in prestigious journals such as New England Journal of Medicine, Antimicrobial Agents and Chemotherapy and European Respiratory Journal.

In The Last Decade

F. Faurisson

26 papers receiving 726 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F. Faurisson France 13 198 173 171 158 135 26 773
Rose Jung United States 18 126 0.6× 163 0.9× 219 1.3× 310 2.0× 424 3.1× 38 1.2k
A. Georgopoulos Austria 17 55 0.3× 48 0.3× 333 1.9× 243 1.5× 125 0.9× 48 883
C. G. Adair United Kingdom 13 271 1.4× 187 1.1× 26 0.2× 122 0.8× 43 0.3× 20 610
Wolfgang A. Krueger Germany 21 486 2.5× 171 1.0× 345 2.0× 552 3.5× 315 2.3× 44 1.5k
Sumathi Nambiar United States 17 75 0.4× 94 0.5× 241 1.4× 241 1.5× 181 1.3× 37 911
Ralph H. Raasch United States 18 82 0.4× 76 0.4× 91 0.5× 368 2.3× 77 0.6× 42 1.2k
James R. Tillotson United States 14 162 0.8× 209 1.2× 92 0.5× 311 2.0× 129 1.0× 23 764
P Aswapokee United States 10 168 0.8× 92 0.5× 407 2.4× 275 1.7× 332 2.5× 19 773
B Hampel Germany 16 35 0.2× 281 1.6× 333 1.9× 359 2.3× 161 1.2× 26 876
Glenn S. Tillotson United States 15 85 0.4× 100 0.6× 283 1.7× 414 2.6× 142 1.1× 38 826

Countries citing papers authored by F. Faurisson

Since Specialization
Citations

This map shows the geographic impact of F. Faurisson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Faurisson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Faurisson more than expected).

Fields of papers citing papers by F. Faurisson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Faurisson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Faurisson. The network helps show where F. Faurisson may publish in the future.

Co-authorship network of co-authors of F. Faurisson

This figure shows the co-authorship network connecting the top 25 collaborators of F. Faurisson. A scholar is included among the top collaborators of F. Faurisson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Faurisson. F. Faurisson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Diot, P., Pierre‐François Dequin, B Rivoire, et al.. (2001). Aerosols and Anti-Infectious Agents. Journal of Aerosol Medicine. 14(1). 55–64. 22 indexed citations
2.
Faurisson, F., É. Lemarié, Frédérique Delatour, et al.. (2001). Urinary excretion reflects lung deposition of aminoglycoside aerosols in cystic fibrosis. European Respiratory Journal. 18(2). 316–322. 32 indexed citations
3.
Faurisson, F., Nicole F. Bernard, S. Friard, et al.. (1999). NEBULIZED CYCLOSPORINE IN THE RAT. Transplantation. 68(2). 191–195. 4 indexed citations
4.
Dautzenberg, Bertrand, Brigitte Fauroux, P. Bonfils, P. Diot, & F. Faurisson. (1998). Bonnes pratiques cliniques de la nébulisation. Annales Françaises d Anesthésie et de Réanimation. 17. 31S–36S. 4 indexed citations
5.
Delatour, Frédérique, et al.. (1998). Effect of a single oral dose of two erythromycin ethylsuccinate formulations on gastric emptying in healthy volunteers: A scintigraphic study. Fundamental and Clinical Pharmacology. 12(3). 292–297. 5 indexed citations
6.
Barry, B., Martine Muffat‐Joly, J Bauchet, et al.. (1996). Efficacy of single-dose ceftriaxone in experimental otitis media induced by penicillin- and cephalosporin-resistant Streptococcus pneumoniae. Antimicrobial Agents and Chemotherapy. 40(9). 1977–1982. 14 indexed citations
7.
Faurisson, F., J.F. Dessanges, A Grimfeld, et al.. (1996). [Comparative study of the performance and ergonomics of nebulizers in cystic fibrosis].. PubMed. 13(2). 155–62. 7 indexed citations
8.
Faurisson, F., J.F. Dessanges, A Grimfeld, et al.. (1995). Nebulizer Performance: AFLM Study. Respiration. 62(1). 13–18. 21 indexed citations
9.
Cochereau-Massin, I, J Bauchet, J M Vallois, et al.. (1994). Kinetics and tolerability of intravitreal pefloxacin in rabbits. Journal of Antimicrobial Chemotherapy. 33(2). 231–242. 9 indexed citations
10.
Cochereau-Massin, I, J Bauchet, Azzam Saleh‐Mghir, et al.. (1993). Efficacy and ocular penetration of sparfloxacin in experimental streptococcal endophthalmitis. Antimicrobial Agents and Chemotherapy. 37(4). 633–636. 21 indexed citations
11.
Gastinne, H., Matthias Wolff, Frédérique Delatour, F. Faurisson, & Sylvie Chevret. (1992). A Controlled Trial in Intensive Care Units of Selective Decontamination of the Digestive Tract with Nonabsorbable Antibiotics. New England Journal of Medicine. 326(9). 594–599. 236 indexed citations
12.
Potel, G., N P Chau, B. Pangon, et al.. (1991). Single daily dosing of antibiotics: importance of in vitro killing rate, serum half-life, and protein binding. Antimicrobial Agents and Chemotherapy. 35(10). 2085–2090. 23 indexed citations
13.
Landman, Roland, et al.. (1991). [Which compressor should be used to deliver pentamidine aerosols with the Respirgard II?].. PubMed. 8(4). 391–5. 1 indexed citations
14.
Cochereau-Massin, I, J Bauchet, F. Faurisson, et al.. (1991). Ocular kinetics of pefloxacin after intramuscular administration in albino and pigmented rabbits. Antimicrobial Agents and Chemotherapy. 35(6). 1112–1115. 17 indexed citations
15.
Pussard, Eric, F. Verdier, F. Faurisson, et al.. (1988). Disposition of amopyroquin in rats and rabbits and in vitro activity against Plasmodium falciparum. Antimicrobial Agents and Chemotherapy. 32(4). 568–572. 10 indexed citations
16.
Pussard, Eric, F. Verdier, F. Faurisson, et al.. (1987). Disposition of monodesethylamodiaquine after a single oral dose of amodiaquine and three regimens for prophylaxis againstPlasmodium falciparum malaria. European Journal of Clinical Pharmacology. 33(4). 409–414. 45 indexed citations
17.
Contrepois, A, N Brion, Jean–Jacques Garaud, et al.. (1985). Renal disposition of gentamicin, dibekacin, tobramycin, netilmicin, and amikacin in humans. Antimicrobial Agents and Chemotherapy. 27(4). 520–524. 43 indexed citations
18.
Garaud, Jean–Jacques, et al.. (1984). Vancomycin pharmacokinetics in critically ill patients. Journal of Antimicrobial Chemotherapy. 14(suppl D). 53–57. 33 indexed citations
19.
Wolff, Markus, et al.. (1983). [Intracisternal concentrations of vancomycin and amikacin after lumbar injections].. PubMed. 12(35). 2185–2185. 3 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rose Jung Breakdown of academic impact, for papers by A. Georgopoulos Breakdown of academic impact, for papers by C. G. Adair Breakdown of academic impact, for papers by Wolfgang A. Krueger Breakdown of academic impact, for papers by Sumathi Nambiar Breakdown of academic impact, for papers by Ralph H. Raasch Breakdown of academic impact, for papers by James R. Tillotson Breakdown of academic impact, for papers by P Aswapokee Breakdown of academic impact, for papers by B Hampel Breakdown of academic impact, for papers by Glenn S. Tillotson
Rankless by CCL
2026